2014
Long‐term outcome in children with infantile spasms treated with vigabatrin: A cohort of 180 patients
Abstract: SUMMARYObjective: Evaluation of efficacy of vigabatrin as the first drug in infants with previously untreated infantile spasms (IS) and reporting the long-term outcome. Methods: We analyzed a cohort of 180 infants with infantile spasms treated with vigabatrin as the first drug. Following initial evaluation and a 48-h basal period for counting the spasms, vigabatrin was administered using the same protocol in all. After 14 days all infants were assessed for therapeutic response (primary outcome). Psychomotor de…
Search citation statements
Paper Sections
Select...
44
13
6
1
Citation Types
4
54
0
2
Year Published
Range
2015
2026
Publication Types
Select...
52
4
1
Relationship
0
57
Authors
Journals
Cited by 56 publications
(60 citation statements)
References 34 publications
4
54
0
2
Smart CitationsHow the paper below cites the one you are viewing
“…In addition to these risk factors, the need for a second-line medication for the initial control of the epileptic spasms was associated with a 2-fold increased OR for development of drug-resistant epilepsy ( P = .005). These findings are consistent with regional and international studies that showed more favorable developmental outcomes in children with infantile spasms of unknown etiology 27,34,35 and is also consistent with studies that showed increased tendency to develop different epilepsy types, particularly Lennox Gastaut syndrome in children with known etiologies of infantile spasms, particularly those with developmental delay and history of seizures before infantile spasms. 60…”
Section: Discussion
supporting
confidence: 90%
Abstract